Stimulation of CD95-induced apoptosis in T-cells by a subtype specific neutral sphingomyelinase inhibitor

Biochemical Pharmacology

Volumn 69, Issue 8, 2005, Pages 1141-1148

  Amtmann, Eberhard ^a   Zöller, Margot ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Arthritis; Autoimmune diseases; Neutral sphingomyelinase; Sphingomyelinase inhibitors; Undecylideneaminoguanidine

Indexed keywords

ANTIMITOTIC AGENT; C 11AG; CELL EXTRACT; FAS ANTIBODY; FAS ANTIGEN; PROTEIN A1; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; APOPTOSIS; ARTHRITIS; ARTICLE; CELL ASSAY; CELL PH; CELL SPECIFICITY; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG DETERMINATION; DRUG EFFECT; DRUG SENSITIVITY; DRUG SPECIFICITY; EDEMA; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 15744376272     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.12.014     Document Type: Article

References (21)

1. S. Tomiuk, K. Hofmann, M. Nix, M. Zumbansen, and W. Stoffel Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci USA 95 1998 3638 3643
2. 2+-dependent neutral sphingomyelinase Proc Natl Acad Sci USA 97 2000 5895 5900
3. Y. Mizutani, K. Tamiya-Koizumi, N. Nakamura, M. Kobayashi, Y. Hirabayashi, and S. Yoshida Nuclear localization of neutral sphingomyelinase. 1. Biochemical and immunocytochemical analyses J Cell Sci 114 2001 3727 3736
4. A.D. Tepper, P. Ruurs, J. Borst, and W.J. van Blitterswijk Effect of overexpression of a neutral sphingomyelinase on CD95-induced ceramide production and apoptosis Biochem Biophys Res Commun 280 2001 634 639
5. W. Stoffel Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo Chem Phys Lipids 102 1999 107 121
6. L. Tonnetti, M.-C. Veri, E. Bonvini, and L. D'Adagio A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction J. Exp. Med. 189 1999 1581 1589
7. S. Schutze, T. Machleidt, and M. Kronke The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction J Leukoc Biol 56 1994 533 541
8. A.H. Merrill Jr., E.M. Schmelz, D.L. Dillehay, S. Spiegel, J.A. Shayman, and J.J. Schroeder Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology Toxicol Appl Pharmacol 142 1997 208 225
9. E. Amtmann, M. Zoller, and G. Schilling Neutral sphingomyelinase- inhibiting guanidines prevent herpes simplex virus-1 replication Drugs Exp Clin Res 26 2000 57 65
10. J.S. Courteney, M.J. Dallman, A.D. Dayan, A. Martin, G. Agarossi, and L. Adorini Immunization against heterologous type II collagen induces arthritis in mice Nature 283 1980 266 267
11. M. Kronke Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes Chem Phys Lipids 101 1999 109 121
12. M. Muzio, A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, and J. Ni FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 1996 817 827
13. J.P. Medema, C. Scaffidi, F.C. Kischkel, A. Shevchenko, M. Mann, and P.H. Krammer FLICE is activated by association with the CD95 death-inducing signaling complex (DISC) EMBO J 16 1997 2794 2804
14. M.E. Peter, F.C. Kischkel, C.G. Scheuerpflug, J.P. Medema, K.M. Debatin, and P.H. Krammer Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex Eur J Immunol 27 1997 1207 1212
15. T. Kobayashi, K. Okamoto, T. Kobata, T. Hasunuma, T. Kato, and H. Hamada Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules Arthritis Rheum 43 2000 1106 1114
16. F. Zipp, R. Martin, R. Lichtenfels, W. Roth, J. Dichgans, and P.H. Krammer Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand J Immunol 159 1997 2108 2115
17. A. Bettinardi, D. Brugnoni, E. Quiros-Roldan, A. Malagoli, S. La Grutta, and A. Correra Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis Blood 89 1997 902 909
18. F. Le Deist, J.F. Emile, F. Rieux-Laucat, M. Benkerrou, I. Roberts, and N. Brousse Clinical, immunological, and pathological consequences of Fas-deficient conditions Lancet 348 1996 719 723
19. W.-X. Zong, L.C. Edelstein, C. Chen, J. Bash, and C. Gelinas The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct target of NFκB that blocks TNFα-induced apoptosis Gen. Develop. 13 1999 382 387
20. L and Bfl-1 J. Immunol. 169 2002 4882 4888
21. Amtmann E, Baader W, Zöller M. Neutral sphingomyelinase inhibitor C11AG prevents lipopolysaccharide induced macrophage activation. Drugs Exp Clin Res, 2003; 29: 5-13.